Following the discoveries of catalytic activity in antibodies raised to transition state analogs, it has become clear that antibodies can catalyze a wide range of chemical reactions that are catalyzed in nature by enzymes. Recent work has focused on chemical reactions that do not occur in natural systems, such as Diels-Alder reactions, which, however, can occur chemically. Catalytic antibodies have the advantage that they can also catalyze reactions that are chemically disfavored due to steric hindrance. It is proposed to study antibody catalysis of disfavored reactions, beginning with the dissection of the catalysis of a highly disfavored syn elimination reaction to form a cis olefin. The second major aim is to elicit antibodies of improved function by utilizing mechanism-based induction. We will be utilizing considerable expertise and experience in the laboratory in hapten design and antibody production and characterization. It is anticipated that fruitful collaborations with the other three projects will follow the beginnings outlined in this proposal, and that structural work will commence shortly using both X-ray crystallography and NMR on several of the catalytic antibodies produced as part of this project. This work will lead to a better understanding of the structural basis of antibody catalysis, and it will give valuable insights into the nature of catalysis in solution in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA027489-19
Application #
6269098
Study Section
Project Start
1998-03-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
19
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Zhu, Xueyong; Tanaka, Fujie; Lerner, Richard A et al. (2009) Direct observation of an enamine intermediate in amine catalysis. J Am Chem Soc 131:18206-7
Kamikubo, Yuichi; Kroon, Gerard; Curriden, Scott A et al. (2006) The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule. Biochemistry 45:3297-306
Zhu, Xueyong; Wentworth Jr, Paul; Kyle, Robert A et al. (2006) Cofactor-containing antibodies: crystal structure of the original yellow antibody. Proc Natl Acad Sci U S A 103:3581-5
Steiner, Derek D; Mase, Nobuyuki; Barbas 3rd, Carlos F (2005) Direct asymmetric alpha-fluorination of aldehydes. Angew Chem Int Ed Engl 44:3706-10
Suri, Jeff T; Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Mimicking dihydroxy acetone phosphate-utilizing aldolases through organocatalysis: a facile route to carbohydrates and aminosugars. Org Lett 7:1383-5
Chowdari, Naidu S; Barbas 3rd, Carlos F (2005) Total synthesis of LFA-1 antagonist BIRT-377 via organocatalytic asymmetric construction of a quaternary stereocenter. Org Lett 7:867-70
Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Direct amino acid-catalyzed asymmetric desymmetrization of meso-compounds: tandem aminoxylation/O-N bond heterolysis reactions. Org Lett 7:1577-80
Suri, Jeff T; Steiner, Derek D; Barbas 3rd, Carlos F (2005) Organocatalytic enantioselective synthesis of metabotropic glutamate receptor ligands. Org Lett 7:3885-8
Tanaka, Fujie; Fuller, Roberta; Barbas 3rd, Carlos F (2005) Development of small designer aldolase enzymes: catalytic activity, folding, and substrate specificity. Biochemistry 44:7583-92
Heine, Andreas; Luz, John G; Wong, Chi-Huey et al. (2004) Analysis of the class I aldolase binding site architecture based on the crystal structure of 2-deoxyribose-5-phosphate aldolase at 0.99A resolution. J Mol Biol 343:1019-34

Showing the most recent 10 out of 155 publications